About
Clinuvel Pharmaceuticals Limited — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 28 2026
CLINUVEL update on Level II ADR upgrade, Nasdaq uplist
Apr 27 2026
FDA relaxes SCENESSE postmarketing requirement
Apr 24 2026
CLINUVEL receives final EMA scientific advice for pivotal Phase III vitiligo study
Apr 24 2026
Final EMA scientific advice for pivotal Phase III vitiligo
Mar 27 2026
CLINUVEL's global programs showcased at AAD
Recent Videos

Cómo comprar acciones de Clinuvel Pharmaceuticals Ltd (CUV.ASX)
Apr 06, 2026

CLINUVEL PHARMACEUTICALS LTD (ASX: CUV) | Daily Analysis Video Report
Sep 12, 2025

Don't Sweat the TECHnique - Photomedicine with Clinuvel
Sep 04, 2025

CLINUVEL FY2025 Annual Results – Investor Webinar
Aug 28, 2025
Translate